Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oxytocin attenuates microglial activation and restores social and non-social memory in APP/PS1 Alzheimer model mice
María Clara Sellés, Juliana T.S. Fortuna, Yasmin P.R. de Faria, et al.
iScience (2023) Vol. 26, Iss. 4, pp. 106545-106545
Open Access | Times Cited: 21

Showing 21 citing articles:

Mechanistic insights and emerging therapeutic stratagems for Alzheimer’s disease
Kayalvizhi Rajendran, Uma Maheswari Krishnan
Ageing Research Reviews (2024) Vol. 97, pp. 102309-102309
Closed Access | Times Cited: 14
A paradoxical switch: the implications of excitatory GABAergic signaling in neurological disorders
Colin J. McArdle, Alana A. Arnone, Chelcie F. Heaney, et al.
Frontiers in Psychiatry (2024) Vol. 14
Open Access | Times Cited: 10
Protective effects of intranasal oxytocin on cognitive dysfunction and hippocampal synaptic plasticity impairment induced by scopolamine
Fariba Houshmand, Khalili Gh, Shkelzen Shabani, et al.
Learning and Motivation (2025) Vol. 89, pp. 102094-102094
Closed Access
Dopamine-driven increase in IL-1β in myeloid cells is mediated by differential dopamine receptor expression and exacerbated by HIV
Stephanie Matt, Rachel Nolan, Samyuktha Manikandan, et al.
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access
The Role of Oxytocin in Alzheimer’s Disease and Its Relationship with Social Interaction
Junpei Takahashi, Daisuke Yamada, Wakana Nagano, et al.
Cells (2023) Vol. 12, Iss. 20, pp. 2426-2426
Open Access | Times Cited: 12
Exogenous Oxytocin Administration Restores Memory in Female APP/PS1 Mice
Philippos Koulousakis, Emily Willems, Melissa Schepers, et al.
Journal of Alzheimer s Disease (2023) Vol. 96, Iss. 3, pp. 1207-1219
Open Access | Times Cited: 11
Non-Peptidic Natural Products that Target and Modulate Oxytocin and Arginine Vasopressin Receptors: Opportunities and Challenges
Dane F. L. Tregeagle, Catherine Doherty, Timothy B. Callis, et al.
Journal of Pharmacological Sciences (2025)
Open Access
Parvalbumin interneuron cell-to-network plasticity: mechanisms and therapeutic avenues
Michael D. Hadler, Henrik Alle, Jörg R. P. Geiger
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 7, pp. 586-601
Open Access | Times Cited: 3
Dementia and neurodegenerative diseases: What is known and what is promising at the cellular and molecular level
Olesia F. Moroz, В. И. Кравченко, Bohdan O. Kushch, et al.
Basic & Clinical Pharmacology & Toxicology (2024)
Closed Access | Times Cited: 2
Linking Social Cognition, Parvalbumin Interneurons, and Oxytocin in Alzheimer’s Disease: An Update
Daniela Černotová, Karolína Hrůzová, David Levčík, et al.
Journal of Alzheimer s Disease (2023) Vol. 96, Iss. 3, pp. 861-875
Open Access | Times Cited: 6
Neuroprotective effects of oxytocin against ischemic stroke in rats by blocking glutamate release and CREB-mediated DNA hypermethylation
Xinyu Fan, Guang Shi, Yunpeng Zhao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115520-115520
Open Access | Times Cited: 5
The Oxytocin Puzzle: Unlocking Alzheimer’s Disease
María Clara Sellés, Maurício M. Oliveira
Journal of Alzheimer s Disease (2024) Vol. 97, Iss. 3, pp. 1101-1104
Closed Access | Times Cited: 1
Peptide discovery across the spectrum of neuroinflammation; microglia and astrocyte phenotypical targeting, mediation, and mechanistic understanding
Benjamin A. Benita, Kyle M. Koss
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 1
The role of neuropeptides (oxytocin, vasopressin, neuropeptide S) in the development of cognitive impairment in Alzheimer’s disease
A. M. Avliyakulyeva, E. K. Kindyakova, S. V. Kuzmina, et al.
Bulletin of Siberian Medicine (2024) Vol. 23, Iss. 1, pp. 105-115
Open Access
Dopamine-driven Increase in IL-1β in Myeloid Cells is Mediated by Differential Dopamine Receptor Expression and Exacerbated by HIV
Stephanie Matt, Rachel Nolan, Samyuktha Manikandan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
mosGraphFlow: a novel integrative graph AI model mining disease targets from multi-omic data
Heming Zhang, Dekang Cao, Tianma Xu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Interplay of MeCP2/ REST/ Synaptophysin-BDNF and intranasal oxytocin influence on Aβ-induced memory and cognitive impairments
Nahid Sarahian, Fariba Khodagholi, Neda Valian, et al.
Behavioural Brain Research (2024) Vol. 476, pp. 115235-115235
Closed Access
Minocycline inhibits microglial activation in the CA1 hippocampal region and prevents long-term cognitive sequel after experimental cerebral malaria
Emílio Telles de Sá Moreira, Millena Lourenço, Tamires Cunha‐Fernandes, et al.
Journal of Neuroimmunology (2024) Vol. 397, pp. 578480-578480
Closed Access
Targeting the hypothalamus for modeling age-related DNA methylation and developing OXT-GnRH combinational therapy against Alzheimer’s disease-like pathologies in male mouse model
Salman Sadullah Usmani, Hyun‐Gug Jung, Qichao Zhang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
Hugging it out
Philippos Koulousakis
(2024)
Open Access
Oxytocin for maintaining mental health in older adults
Ryuzo Orihashi, Yoshito Mizoguchi
Archives of Gerontology and Geriatrics Plus (2024), pp. 100090-100090
Open Access
Does activation of oxytocinergic reward circuits postpone the decline of the aging brain?
B Buemann
Frontiers in Psychology (2023) Vol. 14
Open Access | Times Cited: 1
Page 1

Scroll to top